Opinions
John Sinkins, CFA
Spectrum Pharmaceuticals Inc
SPPI-Q
TRADE
Oct 07, 2003
They have an anti-cancer treatment. Signed a licensing agreement with a major German firm for marketing of their drug.
$6.971
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.